Paper412450
Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
Khairi MR and 5 others. Ann Intern Med, 1977. Cited by 149 papers, by iCite.
Cite this record
ConductScience Library. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. Papers, record 412450. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/412450
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Etidronic Acid | Major topic |
| Osteitis Deformans | Major topic |
| Adult | |
| Aged | |
| Alkaline Phosphatase | |
| Bone Matrix | |
| Bone and Bones | |
| Clinical Trials as Topic | |
| Female | |
| Fractures, Bone | |
| Gastrointestinal Diseases | |
| Humans | |
| Hydroxyproline | |
| Male | |
| Middle Aged | |
| Osteoblasts | |
| Osteoclasts | |
| Pain | |
| Remission, Spontaneous | |
| Risk | |
| Time Factors |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 149 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32714279 | A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/32714279 | PubMed |
| 31848640 | Management of Paget's disease of bone. | Osteoporos Int | 2020 | https://conductscience.org/library/papers/31848640 | PubMed |
| 29192423 | Bisphosphonates for Paget's disease of bone in adults. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/29192423 | PubMed |
| 27562569 | Arterial calcification due to CD73 deficiency (ACDC): imaging manifestations of ectopic mineralization. | Skeletal Radiol | 2016 | https://conductscience.org/library/papers/27562569 | PubMed |
| 23327798 | Skeletal metastasis: treatments, mouse models, and the Wnt signaling. | Chin J Cancer | 2013 | https://conductscience.org/library/papers/23327798 | PubMed |
| 19652650 | Paget disease: when to treat and when not to treat. | Nat Rev Rheumatol | 2009 | https://conductscience.org/library/papers/19652650 | PubMed |
| 18504638 | Management of patients with Paget's disease: a consensus document of the Belgian Bone Club. | Osteoporos Int | 2008 | https://conductscience.org/library/papers/18504638 | PubMed |
| 16937267 | Guidelines for diagnosis and management of Paget's disease of bone in Japan. | J Bone Miner Metab | 2006 | https://conductscience.org/library/papers/16937267 | PubMed |
| 10647976 | Drug-induced diarrhoea. | Drug Saf | 2000 | https://conductscience.org/library/papers/10647976 | PubMed |
| 9122100 | Paget's disease of bone. | Postgrad Med J | 1997 | https://conductscience.org/library/papers/9122100 | PubMed |
| 7506648 | Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. | Drugs | 1993 | https://conductscience.org/library/papers/7506648 | PubMed |
| 6809282 | Focal mineralization defect during disodium etidronate treatment of calcinosis. | Calcif Tissue Int | 1982 | https://conductscience.org/library/papers/6809282 | PubMed |
| 6793126 | Paget's disease of bone. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6793126 | PubMed |
| 6791792 | Effect of sodium etidronate and phenytoin of Pagetic bone. | Calcif Tissue Int | 1981 | https://conductscience.org/library/papers/6791792 | PubMed |
| 6456054 | Effects of two diphosphonates (EHDP and Cl2MDP) on serum uric acid in pagetic patients. | Calcif Tissue Int | 1981 | https://conductscience.org/library/papers/6456054 | PubMed |
| 6442196 | Monitoring the treatment of Paget's disease with etidronate. | Calcif Tissue Int | 1984 | https://conductscience.org/library/papers/6442196 | PubMed |
| 3928323 | Paget's disease of bone. An update on management. | Drugs | 1985 | https://conductscience.org/library/papers/3928323 | PubMed |
| 3918513 | Clinical experience with the use of two diphosphonates in the treatment of Paget's disease. | Ann Rheum Dis | 1985 | https://conductscience.org/library/papers/3918513 | PubMed |
| 3107689 | Treating Paget's disease. | Br Med J (Clin Res Ed) | 1987 | https://conductscience.org/library/papers/3107689 | PubMed |
| 3090346 | [Diphosphonate for the prevention of an increased ossification process]. | Klin Wochenschr | 1986 | https://conductscience.org/library/papers/3090346 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/412450
GET https://conductscience.org/api/papers/v1/412450/cited_by?page=2